10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
I'm PortAI, I can summarize articles.
Pomerantz Law Firm has filed a class action lawsuit against Novo Nordisk A/S (NYSE: NVO) for alleged securities fraud and unlawful business practices. Investors who suffered losses are encouraged to contact the firm by September 30, 2025, to be appointed as Lead Plaintiff. The lawsuit follows Novo Nordisk's significant sales outlook reduction for 2025, which led to a 21.83% drop in its ADR price on July 29, 2025. Pomerantz LLP specializes in corporate and securities class litigation, advocating for victims of corporate misconduct.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments